Therma Bright Inc V.THRM

RE:BARCHART FOR LOCKDOWN 2020

[Zimmee1]

Perhaps THRM is still waiting for the Big Day News Releases and I check on
Yahoo finance and nothing there:

Therma Bright Inc. (THRM.V)

TSXV - TSXV Real Time Price. Currency in CAD

Add to watchlist

0.4300+0.0050 (+1.18%)

As of 10:55AM EDT. Market open.

 

• Financials

• 1D
• 5D
• 1M
• 6M
• YTD
• 1Y
• 5Y
• Max

Previous Close	0.4250
Open	0.4300
Bid	0.4250 x 0
Ask	0.4350 x 0
Day's Range	0.4150 - 0.4300
52 Week Range	0.0650 - 1.0500
Volume	158,715
Avg. Volume	889,471

Market Cap	94.041M
Beta (5Y Monthly)	3.79
PE Ratio (TTM)	N/A
EPS (TTM)	-0.0410
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

 

 

All

News

Press Releases

• Newsfile•16 days ago

  Therma Bright Provides Update for its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

  Toronto, Ontario--(Newsfile Corp. - October 4, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company and developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test, provides the following update for its AcuVidTM Covid-19 Rapid Saliva Antigen Test.Therma Bright filed its application for EUA approval to market its AcuVid™ Covid-19 Rapid Antigen Saliva Test with the US FDA on as previously reported on July 22nd and September ...
• AdTourisme Montral

  A bustling Parisian street? Not exactly.

  Romantic alleys, historic culture and fabulous gastronomy. Montral gives you Paris, just a drive away! Plan your fall trip to Montral.

• Newsfile•last month

  Therma Bright Successfully Up-lists to the OTCQB Venture Market Under Symbol TBRIF

  Provides Update on FDA-EUA Application Process Toronto, Ontario--(Newsfile Corp. - September 14, 2021) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announced today its successful up-listing from the OTC Pink Sheets to the OTCQB® Venture Market (the "OTCQB"). Therma Bright will commence trading on the OTCQB with the market ope
• Newsfile•2 months ago

  Therma Bright Provides Update on FDA-EUA Application Process

  Toronto, Ontario--(Newsfile Corp. - September 1, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide an update on its AcuVid™ Saliva Test with the US Food & Drug Administration's Emergency Use Authorization (EUA) application."During the past 30 days, the Therma Bright team has been actively engaged with officials at the
• Newsfile•2 months ago

  Therma Bright Enters into Securities for Services Agreement, Debt Settlement, and Issues Options

  Toronto, Ontario--(Newsfile Corp. - August 12, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its 'smart-enabled' AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, advises that it has entered into a securities for services agreement with a consultant to provide services related to the development and opening up of new retail distribution channels/outlets for the Company and the development and opening u
• Newsfile•2 months ago

  Therma Bright Finalizes Agreement with Afero for Its Smart-Enabled AcuVid(TM) Saliva Test

  Company To Begin Embedding Solution Onto Each 15-Minute COVID-19 Rapid Antigen Test Cartridge Toronto, Ontario--(Newsfile Corp. - August 5, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its 'smart-enabled' AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce it has completed the definitive partnership agreement with Afero, Inc. Afero's next-generation Intelligent Edge "Smart" Platfo
• AdDefinition

  If You See This In Australia, Get Away Immediately

  This Is Why You Should Never Play With Any Wild Animals In Australia

• Newsfile•3 months ago

  Therma Bright Files Application to the OTCQB and DTC Clearing

  Toronto, Ontario--(Newsfile Corp. - July 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has applied for OTCQB listing and full eligibility through the Depository Trust Company (DTC), a subsidiary of the Depository Trust & Clearing Corp., which manages the electronic clearing and settlement of publicly
• CNW Group•3 months ago

  IIROC Trading Resumption - THRM

  Trading resumes in:
• Newsfile•3 months ago

  Therma Bright Awaits FDA-EUA Approval From Over 260 AcuVid(TM) Clinical Study Test Results

  Toronto, Ontario--(Newsfile Corp. - July 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide an update on its AcuVid™ COVID-19 Rapid Antigen Saliva Test and awaits an official response from the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) review for its COVID-19 rapid antigen test applic
• CNW Group•3 months ago

  IIROC Trading Halt - THRM

  The following issues have been halted by IIROC:
• AdConnect Hearing

  What's the Average Price of a Hearing Aid in 2021

  The latest hearing aids are invisible, totally rechargeable and affordable - and they're now available in Canada. Find out if you qualify for deals.

• Newsfile•3 months ago

  Therma Bright's AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Successfully Detects the COVID-19 Delta Variant Strain

  Toronto, Ontario--(Newsfile Corp. - July 8, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce the completion and validation that its AcuVid™ COVID-19 Rapid Antigen Saliva Test successfully detected the highly contagious, fast moving COVID-19 Delta B.1.617.2 variant. The AcuVid™ / Delta variant study was completed at
• Newsfile•4 months ago

  Therma Bright Secures US Distributor 'DME Authority' for Its Patented Venowave Lightweight Deep Vein Thrombosis (DVT) Device, Just as US Healthcare Providers Deal with Device Shortages

  Toronto, Ontario--(Newsfile Corp. - June 28, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has secured an exclusive US distributor, a Nashville, Tennessee based organization, DME Authority for Therma's patented FDA approved Venowave, a lightweight Deep Vein Thrombosis (DVT) prophylaxis device. The multi-y
• Newsfile•4 months ago

  Therma Bright to Test AcuVid(TM) on the Highly Contagious COVID-19 Delta Variant, Company Completes Brazilian Clinical Study for Final FDA EUA Submission

  Toronto, Ontario--(Newsfile Corp. - June 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it will test the SARS-CoV-2 (COVID-19) Delta variant, first detected in India, with its AcuVid™ antigen saliva test. Governments and global health experts have expressed deep concerns that the highly contagious, fast s
• Newsfile•4 months ago

  Therma Bright Reports Performance of Its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test from Brazilian Clinical Study

  Toronto, Ontario--(Newsfile Corp. - June 17, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and a progressive medical device technology company, is pleased to provide an update on the exceptional performance of its AcuVid™ COVID-19 Rapid Antigen Saliva Test's Brazilian Clinical Study, conducted in Minas Gerais, Brazil."The ongoing clinical study for our AcuVid™ COVID-19 Rapid Antigen Saliva Test has performed extre
• AdMoneypail

  Wealthiest Women in the World, Ranked by Net Worth

  The richest women don't get as much attention as they should.

• Newsfile•5 months ago

  Therma Bright Provides Update on Brazilian Clinical Study

  Company advances final validation efforts of its AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Toronto, Ontario--(Newsfile Corp. - May 27, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to provide the following update on its Brazilian clinical study of its innovative 15- minute COVID-19 antigen saliva test.Following last week's announcement on securing K-One ...
• Newsfile•5 months ago

  Therma Bright Secures Development and Manufacturing Partner for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test

  K-One MediTech To Begin Production of CE approved 15-Minute Antigen Test Solution Toronto, Ontario--(Newsfile Corp. - May 21, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has secured a development and manufacturing partnership with K-One MediTech to bring the Acuvid™ COVID-19 Rapid Antigen Saliva Test Kit to the ...
• Newsfile•5 months ago

  Therma Bright Enters into Agreement to Distribute a 15 Minute Rapid COVID-19 Antibody Test

  Toronto, Ontario--(Newsfile Corp. - May 6, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has entered into a distribution agreement to white label and distribute a 15-minute rapid COVID-19 antibody test for detecting IgG and IgM antibodies against SARS-CoV-2. The new product will be branded Therma ...
• Newsfile•6 months ago

  Therma Bright Partners With Afero To Make AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Smart-Enabled

  Silicon Valley tech firm brings encrypted solution for tracking Canadian developer's 15-minute Covid19 rapid antigen test for point of care, and then at-home testing Toronto, Ontario--(Newsfile Corp. - April 28, 2021) - Afero has entered into a memorandum of understanding (MOU) agreement with Therma Bright Inc. (TSXV: THRM), the "Company" or "Therma Bright"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies. The mutually beneficial partnership ...
• AdForbes.com

  Here Are 20 Brand-New Electric Vehicles Worth Wait

  Here’s a quick look at 20 of the most significant electrified rides expected to reach dealers’ showrooms in the months ahead.

• Newsfile•6 months ago

  Therma Bright's AcuVid(TM) COVID-19 Rapid Antigen Saliva Test Detects the Important SARS-CoV-2 Variants of Concern; the Brazilian P.1 and P.2 and the UK B.1.1.7 Variants

  Toronto, Ontario--(Newsfile Corp. - April 22, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce successful preliminary results with its AcuVid™ COVID-19 Rapid Antigen Saliva Test to detect the SARS-CoV-2 Variants of Concern ("VOC") that are rapidly spreading across Canada and many other countries; specifically the Brazilian P.1 and ...
• Newsfile•6 months ago

  Therma Bright Announces EU-CE Approval for AcuVid(TM) COVID-19 Rapid Antigen Saliva Test and Conditional Sale for 100,000 CE-only AcuVid(TM) Test Kits

  New global distribution partner McWilliams Collective secures test kit order from European client Toronto, Ontario--(Newsfile Corp. - April 19, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has received CE approval certification from an EU competent authority of Belgium for its AcuVid™ COVID-19 Rapid Antigen Saliva Test, and has ...
• Newsfile•6 months ago

  Therma Bright Provides Update on Brazilian Performance Study of its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

  Toronto, Ontario--(Newsfile Corp. - April 13, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that an initial phase of the Brazilian study of the AcuVid™ saliva-based rapid antigen test has been completed. Dr. Ricardo Fujiwara, from the Federal University of Minas Gerais, stated that, "The AcuVid™ initial results confirm the ...
• Newsfile•7 months ago

  Therma Bright Receives IRB Approval and Submits Application to Health Canada to Begin Clinical Study for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

  Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVid™ Covid-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has received IRB approval and subsequently submitted to Health Canada seeking approval to conduct a clinical performance study of its AcuVidTM Covid-19 Rapid Saliva-based Antigen Test.Therma's clinical research organization prepared and filed the necessary ...
• AdStandardNews

  This Yacht Is Why Jeff Bezo Will Return To Earth

  This thing is unreal.

• Newsfile•7 months ago

  Therma Bright Partners with Ridge Global to Expand Its United States and Global Reach

  Toronto, Ontario--(Newsfile Corp. - March 24, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the AcuVidTM COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announces that it has entered into business agreement with Ridge Global, the consultancy founded by Governor Tom Ridge, the first U.S. Secretary of Homeland Security. The agreement focuses on supporting the Company's reach across the United States and Global marketplace ...
• Newsfile•7 months ago

  Therma Bright Initiates Clinical Performance Study in Brazil for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

  Toronto, Ontario--(Newsfile Corp. - March 18, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has entered into an agreement with Safetest Diagnsticos("Safetest") of Brazil in partnership with the Federal University of Minas Gerais to conduct a clinical performance study of its AcuVidTM COVID-19 Rapid Saliva-based Antigen Test.Brazil's increase in its COVID-19 infection rate in the past week set another ...
• Newsfile•7 months ago

  Therma Bright Submits Application to Research Ethics Board for Approval of Clinical Trials for AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

  Toronto, Ontario--(Newsfile Corp. - March 11, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has submitted an application to an independent Research Ethics Board ("REB") for approval to conduct a clinical study with the Company's AcuVid TM rapid antigen test for detecting SARS CoV-2 virus in saliva. Approval is expected within a week, at which point Therma will ...
• Newsfile•8 months ago

  Therma Bright Enters into Clinical Trial Agreement for its AcuVid(TM) COVID-19 Rapid Saliva-Based Antigen Test

  Toronto, Ontario--(Newsfile Corp. - February 26, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that it has entered into an agreement with a COVID-19 testing site located in the Greater Toronto Area to conduct a clinical study with the Company's AcuVid TM rapid antigen test for detecting SARS-CoV-2 virus in saliva. The testing site is located within the Greater Toronto Area ...
• AdBest Hearing Aids

  Pensioners in Canada Snap Up Amazing New Hearing Aid

  Hearing aids aren't the clunky overpriced monstrosities they used to be. The tech is the best it has ever been and they are nearly invisible now.

•  
• Newsfile•9 months ago

  Therma Bright Adds $1,171,875 to Treasury Through Exercise of Warrants and Options

  Toronto, Ontario--(Newsfile Corp. - January 29, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that in the past month, investors have exercised a total of 7,582,500 warrants and options to add $1,171,875 to the Company's treasury. With the addition of the $300,000, as previously reported in the press release on December 24th, 2020, the Company has added a total ...
• Newsfile•9 months ago

  Therma Bright Acquires 100% Control of its COVID-19 Rapid Saliva Antigen Test and Announces Proposed Name Change for the Test

  Toronto, Ontario--(Newsfile Corp. - January 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company announces that it has taken 100% control of the research and development, regulatory, manufacturing and commercialization of its saliva-based rapid antigen test. As a result, Therma Bright will retain 100% of all future revenue and profits from the sale of the saliva-based rapid antigen test. Therma Bright previously ...
• Newsfile•9 months ago

  Therma Bright Reports Improved Accuracy For Its COVID-19 Rapid Saliva Antigen Test, CoviSafeTM, And Prepares For Prospective Studies

  Toronto, Ontario--(Newsfile Corp. - January 18, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce that the most recent results achieved with nanoComposix using banked human saliva samples and utilizing a CoviSafe™ prototype device indicate a test sensitivity of 86% and a specificity of 100% for Therma's CoviSafe™ rapid antigen test for detecting SARS-CoV-2 virus in saliva. As previously reported on December ...
• AdBonvoyaged

  The Real Wild West Was Rougher Than You Thought

  These vintage photos prove you wouldn't last two days in the real Wild West...

• CNW Group•9 months ago

  Co-op partners with Indigenous communities to build Western Nations Gas Bars

  Western Nations, fuelled by Co-op, will support strong, vibrant communities through mutually beneficial relationships built on shared valuesSASKATOON, SK, Jan. 18, 2021 /CNW/ - Federated Co-operatives Limited (FCL), in consultation with Indigenous leaders and communities across Western Canada, has developed the new, exclusive Western Nations gas bar brand.
• Newsfile•9 months ago

  Therma Bright Adds Veteran Manufacturing Expert to Advisory Team to Advance its Saliva-Based Rapid Antigen Test CoviSafe(TM)

  Toronto, Ontario--(Newsfile Corp. - January 15, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce the appointment of Ian Levine to the advisory board to assist with future scaling for the manufacture of CoviSafe™.Mr. Levine will build the overall operations for the Therma Bright team to secure efficient and smooth delivery of CoviSafe™ to our global customers. Mr. Levine's experience in ...
• Baystreet•10 months ago

  Stocks in play: Therma Bright Inc.

  Has engaged Barwicki Investor Relations to provide investor relations services to the Company. Founded ...
• Newsfile•10 months ago

  Therma Bright Signs IR Agreement with Barwicki Investor Relations, Adds $300,000 to Treasury Through Exercise of Warrants and Options; and Grants Options

  Toronto, Ontario--(Newsfile Corp. - December 24, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, announces that it has engaged Barwicki Investor Relations to provide investor relations services to the Company. Founded by Andrew Barwicki in 2006, Barwicki Investor Relations is a full service investor relations firm representing publicly traded companies and pre-IPO companies. Andrew Barwicki has 25+ years experience in finance, investor relations, ...
• AdYahoo! Style

  Clever storage ideas for every room in your home

  From the bedroom to the garage, here's how to free up valuable floor space and make better use of every nook and cranny.

• Newsfile•10 months ago

  Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva Test, CoviSafe(TM)

  Toronto, Ontario--(Newsfile Corp. - December 7, 2020) -  Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, is pleased to announce the preliminary results achieved during the feasibility studies indicate a test sensitivity of 80% and a specificity of over 90% for Therma's CoviSafe™ rapid test for detecting SARS-CoV-2 in saliva. Therma entered into an agreement with nanoComposix, a developer and manufacturer of rapid diagnostic tests to ...
• CNW Group•11 months ago

  Outaouais paramedics now have access to telemedicine

  Partnership with Dialogue will ensure unlimited access to quality virtual care for front-line professionals GATINEAU, QC, Nov. 24, 2020 /CNW Telbec/ - The Outaouais Paramedic Cooperative, in partnership with Dialogue, Canada's virtual care leader, is pleased to announce that its 250 members and their families will now have access to virtual health care.
• Newsfile•11 months ago

  Therma Bright Creates New Venture, Torion Biosciences to Develop its COVID-19 Rapid Antigen Test, CoviSafe(TM)

  Therma Bright Investigates Spinoff of its Consumer Products Toronto, Ontario--(Newsfile Corp. - November 4, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma Bright" or the "Company"), a progressive medical device technology company announces that it has created a new venture, called Torion Biosciences Inc. ("Torion") with a mandate to develop, license and commercialize a rapid antigen test for screening of both symptomatic and asymptomatic individuals, infected or suspected of being infected with the COVID-19 virus. ...
• Newsfile•last year

  Therma Bright and Orpheus Medica Advance CoviSafe(TM) Rapid Saliva Test to Formal Product Developmental Phase

  Successful Completion of the feasibility Studies followed by engagement of nanoComposix to accelerate the development of CoviSafe(TM) Toronto, Ontario--(Newsfile Corp. - October 21, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical device technology company, and its co-development partner, Orpheus Medica Inc. ("Orpheus") are pleased to announce the successful completion of the initial feasibility studies with its polypeptide detection candidates for CoviSafe™. Therma & Orpheus are also pleased to announce ...
•  

   

   

   

   

   

   

   

   

   

   

   

   

   

  AdInteractive Brokers

  Earn Extra Income with Stock Yield Enhancement